Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Blood Cancer Journal, Published online: 11 January 2023; doi:10.1038/s41408-022-00763-wPevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Source: Blood Cancer Journal - January 11, 2023 Category: Hematology Authors: Pallawi Torka Swetha Kambhampati Lu Chen Xiaoguang Wang Canping Chen Dan Vuong Hanjun Qin Alexandra Muir Kirsten Orand Ivana Borja D. Lynne Smith Alex F. Herrera Stephen E. F. Spurgeon Byung Park Lionel D. Lewis Francisco Hernandez-Ilizaliturri Zheng Xia Source Type: research